Clinical trial of Bu Shen Yi Qi Fang on treating atopic dermatitis

Clinical trial of Bu Shen Yi Qi Fang on treating atopic dermatitis in Deficiency of Kidney Yang and Qi

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000562

Enrollment

Unknown

Registered

2009-10-22

Start date

2009-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

B:Imitation of Bu Shen Yi Qi Fang + Desloratadine tablet

A:Bu Shen Yi Qi Fang + Desloratadine tablet

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 70 years old, male or female; 2.Able and willing to provide signed informed consent; 3.Patients with low moderate atopic dermatitis, SCORAD<=50; 4.Qi deficiency syndrome, kidney qi and yang deficiency syndromeaccording to Traditional Chinese medical Differentiation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe atopic dermatitis or Oral glucocorticoid treatment; 2. Participated in clinical trials of other drugs for the past three months; 3. Patients who have previous cancer treatments; 4. Uncontrolled heart failure/infection or liver or Renal failure; 5. Previous diagnostic other skin diseases that may affect evaluation of the study results; 6. Hyperactivity of fire due to yin deficiency syndrome according to Traditional Chinese medical Differentiation; 7. Pregnant or planning pregnancy, breast-feeding women.

Design outcomes

Primary

Measure	Time frame
SCORAD;	—

Secondary

Measure	Time frame
Traditional Chinese symptom scores, VAS, DLQI, nights of waken, days without itches, Quality of life;	—

Countries

China

Contacts

Public ContactDong Jingcheng

jcdong2004@126.com+86 021 52888301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026